The SPEAR UltraDetect ™ pTau 217 biomarker assay kit is a specialized tool for researching Alzheimer’s disease (AD) using ...
The National Agency for Food and Drug Administration and Control has warned healthcare providers, patients, and the public ...
Doctors address the pros and cons of Health Resources and Services Administration’s new guidance, including at-home self-collection for cervical cancer screening.
This article explores multiplexing applications in biopharma and highlights key assay development factors to consider.
Medical Device Network on MSN
NG Biotech announces FDA approval for diagnostic assays
NG Biotech manufactured the assays in France, with Hardy Diagnostics serving as the exclusive distributor in the US.
The Initiative helps clinicians align their clinical practice with updated NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) Melanoma (Version 1.2026) frameworkProvides T1b and ...
Heightened immune response to flagellins in commensal gut microbes predicted future CD in healthy first-degree relatives of patients.
There’s been talk about liquid biopsies and the promise of using blood samples to test for a wide variety of cancers at once.
The assay is designed to encourage informed patient-physician decision-making when choosing a treatment option in localised ...
Yet overall performance was good with both the ESC and High-STEACS strategies, leaving hospitals room to choose.
Creating a clear and well-defined bioanalytical methodology to quantify humoral and cellular immune responses is critical for ...
Heterotopic ossification (HO) is a common post-surgery condition where bone abnormally forms within soft tissues. A new study out of Mass General Brigham assesses the viability of a simple blood test ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results